Total 65Articles, Present Page 3/7
-
45MDFS grants Marketing Authorization for COVID-19 treatment, Regkirona Inj. [Press Release, Feb 5, 2020]
-
0205 Marketing Authorization for COVID-19 treatment, Regkirona Inj..pdf
2021-02-05 -
-
44Meeting Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics [Press Release, Jan 18, 2020 / unofficial translation ]
-
(1.18) Results of the Advisory Committee for the Safety and Efficacy Assessment of COVID-19 Therapeutics.pdf
2021-02-03 -
-
43Updates on the approval and review of COVID-19 therapeutics and vaccines (1) [Press Release, Jan 11, 2020]
-
(210111) Updates on the approval and review of COVID-19 therapeutics and vaccines (1).pdf
2021-01-18 -
-
42Key features and mechanism of action of COVID-19 vaccines [Press Release, Jan 22, 2020]
-
(1.7) 코로나19 백신의 특징 및 작용원리(영문용)_eng1.pdf
2021-01-15 -
-
41MFDS begins review of Astrazeneca’s COVID-19 vaccines [Press Release, Jan 4, 2021]
-
(1.4) 아스트라제네카 코로나19 백신 허가·심사 착수_eng_수정.pdf
2021-01-08 -
-
40[Press Release, Dec 31, 2020] COVID-19 vaccine developed in Korea approved for clinical trial (Phase I/II)
-
(12.31) [보도자료] 국내 개발 코로나19 백신(1·2상) 임상 승인_eng_최종취합수정.pdf
2021-01-07 -
-
39[Press Release, Dec. 29, 2020] MFDS begins review of Celltrion’s COVID-19 monoclonal antibody therapy
-
(12.29) 셀트리온 코로나19 치료제 허가·심사 착수_eng4.pdf
2021-01-05 -
-
38[Press Release, Dec 22, 2020 ] MFDS begins rolling reviews of Janssen’s (Johnson&Johnson’s) COVID-19 vaccine
-
(12.22) 식약처, 얀센社(존슨앤드존슨) 코로나19 백신 사전검토 착수_eng.pdf
2020-12-31 -
-
37[Press Release, Dec 18, 202] MFDS begins rolling review of Pfizer’s COVID-19
-
(12.18)식약처, 화이자社 코로나19 백신 사전검토 착수.pdf
2020-12-31 -
-
36[Press Release, Dec 4, 2020] International Standard on Infectious Disease Diagnostics, 1st K-quarantine model to be approved as international standard
-
12.4 (부처합동) K-방역을 국제사회와 공유하기 위한 감염병 진단검사기법 관련 국제표준 제정_eng_ _최종.pdf
2020-12-08 -